Abstract
HIV-1 exerts its most profound effects through destruction of the hosts immune responses specifically through targeting of the T-lymphocyte populations. In addition to its primary immune target, HIV-1 also targets cells of the nervous, skeletal and vascular system. There is emerging evidence to suggest that HIV-1 may, in part at least, affect these diverse tissues by impairing the homeostatic production of terminally differentiated cells from stem and progenitor cell populations. The interaction between HIV-1 and stem cell populations may serve to underpin the diverse nonimmunological effects of HIV-1. This review deals with the effect of HIV-1 infection on a number of progenitor cell types, with emphasis on delineating mechanisms of HIVs destructive effect on the body. Modification of these effects may represent novel avenues for exploration in our search for clinical interventions.
Current HIV Research
Title: Progenitor Cell Types in HIV-1 Infection: Bioactivity and Emerging Targets for Treatment
Volume: 7 Issue: 5
Author(s): Eoin J. Cotter, Peter P. Doran and William G. Powderly
Affiliation:
Abstract: HIV-1 exerts its most profound effects through destruction of the hosts immune responses specifically through targeting of the T-lymphocyte populations. In addition to its primary immune target, HIV-1 also targets cells of the nervous, skeletal and vascular system. There is emerging evidence to suggest that HIV-1 may, in part at least, affect these diverse tissues by impairing the homeostatic production of terminally differentiated cells from stem and progenitor cell populations. The interaction between HIV-1 and stem cell populations may serve to underpin the diverse nonimmunological effects of HIV-1. This review deals with the effect of HIV-1 infection on a number of progenitor cell types, with emphasis on delineating mechanisms of HIVs destructive effect on the body. Modification of these effects may represent novel avenues for exploration in our search for clinical interventions.
Export Options
About this article
Cite this article as:
Cotter J. Eoin, Doran P. Peter and Powderly G. William, Progenitor Cell Types in HIV-1 Infection: Bioactivity and Emerging Targets for Treatment, Current HIV Research 2009; 7 (5) . https://dx.doi.org/10.2174/157016209789346282
DOI https://dx.doi.org/10.2174/157016209789346282 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pre-Clinical Considerations in the Assessment of Immunogenicity for Protein Therapeutics
Current Drug Safety Current Status of Anti-Picornavirus Therapies
Current Pharmaceutical Design Disease-Induced Neuroinflammation and Depression
CNS & Neurological Disorders - Drug Targets Gene Therapy and Targeted Toxins for Glioma
Current Gene Therapy Intracellular Amyloid β-Protein and Its Associated Molecules in the Pathogenesis of Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Impact of Latent Viral Infections in Mechanically Ventilated Patients
Current Respiratory Medicine Reviews Therapeutic Targeting of Chemokines and Chemokine Receptors in Multiple Sclerosis: Opportunities and Challenges
CNS & Neurological Disorders - Drug Targets Mechanisms of Neuronal Injury and Death in HIV-1 Associated Dementia
Current HIV Research <i>In Silico</i> Analysis of Drug Repurposing Strategy for the Identification of Potential NS3 Helicase Inhibitors Against Zika Virus
Current Chinese Science Enterovirus D-68 Molecular Virology, Epidemiology, and Treatment: an Update and Way Forward
Infectious Disorders - Drug Targets Identification of Novel 5,6-Dimethoxyindan-1-one Derivatives as Antiviral Agents
Medicinal Chemistry Cytokine Network in Inflammatory Bowel Disease
Current Drug Targets - Inflammation & Allergy MicroRNAs: Key Players in Microglia and Astrocyte Mediated Inflammation in CNS Pathologies
Current Medicinal Chemistry Drug Trials in Dementia: Challenging Ethical Dilemmas
Current Alzheimer Research Clinical Use of Rituximab in Patients with HIV Related Lymphoma and Multicentric Castlemans Disease
Current Drug Delivery Is Helicobacter pylori the Infectious Trigger for Headache?: A Review
Infectious Disorders - Drug Targets Directing the Antiretroviral Drugs to the Brain Reservoir: A Nanoformulation Approach for NeuroAIDS
Current Drug Metabolism The Neuroscience of Maternal Behaviour
Current Psychiatry Reviews Neurotrophic Factors in the Pathogenesis of Neurological Disorders with Mental Retardation in Children
Current Pediatric Reviews Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review
Current Neuropharmacology